Novel and potent telomerase antagonist (GRN163L) inhibits telomerase activity, resulting in telomere shortening and apoptosis of multiple myeloma cells
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Harvard University, Dana-Farber Cancer Institute
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2280060180
